NCT04814381View on ClinicalTrials.gov

Ketamine + Magnesium for Chronic Cluster Headache (KETALGIA)

PHASE4RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

September 15, 2021

Primary Completion Date

September 15, 2026

Study Completion Date

December 31, 2026

Conditions
Refractory Chronic Cluster Headache
Interventions
DRUG

Ketamine + Magnesium sulfate (drug combination)

A single infusion will be performed over 2 hours with 90 days follow-up.

Trial Locations (14)

13005

RECRUITING

AP-HM Marseille, Marseille

31059

RECRUITING

Hopital Pierre Paul Riquet, Toulouse

33520

RECRUITING

Polyclinique Jean Villar, Bruges

34070

RECRUITING

Clinique Beau Soleil, Montpellier

34295

RECRUITING

CHU de Montpellier, Montpellier

38500

NOT_YET_RECRUITING

CHU Grenoble-Alpes, Voiron

44000

RECRUITING

CHU Nantes, Hopital Nord Laennec, Nantes

59000

RECRUITING

CHRU De Lille, Lille

63000

RECRUITING

CHU de Clermont-Ferrand, Clermont-Ferrand

67098

RECRUITING

Hopital de Hautepierre, Strasbourg

69500

RECRUITING

Hospices civils de Lyon, Hôpital Pierre Wertheimer, Lyon

74370

RECRUITING

CH Annecy Genevois, Annecy

75010

RECRUITING

Hôpital Lariboisière, Paris

76100

RECRUITING

CHU Rouen, Rouen

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

University Hospital, Clermont-Ferrand

OTHER